Gujarat-based Aptus Pharma is accelerating its transformation into a diversified healthcare player with a strategic expansion into life-saving injectables and ICU care products, while simultaneously strengthening its footprint in the fast-growing OTC and cosmeceutical segments.
Building on its recent entry into the OTC and uro care space, the company has now set its sights on high-acuity hospital therapies. The new portfolio will focus on life-saving injectables designed for the management of severe infections, sepsis, and other critical care conditions, products that are primarily administered in hospital and intensive care settings.
This move marks a significant step in Aptus Pharma’s broader ambition to deepen its presence across prescription, institutional, and retail healthcare segments. By entering the critical care category, the company is aligning itself with a high-value therapeutic segment that demands stringent quality standards, clinical reliability, and strong hospital partnerships.
Strengthening Presence Across Healthcare Verticals
The expansion into ICU and injectable therapies complements the company’s parallel push in consumer healthcare. Recently, Aptus Pharma announced a substantial scale-up of its OTC operations in Gujarat under its dedicated Aptus Well Care division. The initiative focuses on high-demand categories such as face care, body and skin care, and hair care—segments witnessing sustained consumer growth.
Flagship brands including Timglo, Kerava, and Shirovita are expected to anchor this growth, targeting strong traction across key markets in the state. As part of its forward-looking strategy, the company is also preparing to launch new products in hygiene care, pain relief, and oral care. Upcoming SKUs such as Timglo Detox and Kerava Shea Moisturizer are set to broaden its appeal in the expanding personal care space.
Expanding Reach, Enhancing Capabilities
To support this dual-track growth strategy, Aptus Pharma is strengthening its field force and distributor network. The objective is clear: significantly increase the availability of its OTC portfolio across medical stores throughout Gujarat, thereby capturing a larger share of the state’s rapidly evolving OTC and personal care market.
At the same time, the entry into life-saving injectables signals a deeper institutional engagement, positioning the company within hospital procurement ecosystems and intensive care settings—an arena that enhances both credibility and revenue potential.
A Balanced Growth Strategy
By expanding into critical care therapeutics while scaling up consumer-focused healthcare products, Aptus Pharma is building a balanced portfolio spanning high-acuity hospital treatments and everyday wellness solutions.
The integrated approach reflects a long-term growth strategy—one that seeks to combine institutional strength with retail reach, ensuring resilience across multiple healthcare segments and reinforcing the company’s position as an emerging, diversified pharmaceutical player in Gujarat and beyond.